Tuberculosis control in the South-East Asia Region: Annual Report 2016
AbstractThe South-East Asia Region of WHO is home to 26% of the world's population; however, the Region accounts for 41% of the global burden of tuberculosis (TB) in terms of disease incidence. In 2014, there were an estimated 5.4 million prevalence and 4 million incidence of TB, and about 460 000 people died due to TB in the Region. India and Indonesia have among the largest numbers of cases (23% and 10% of the global total, respectively). An estimated 340 000 children in the South-East Asia Region developed TB in 2014. The region has a total of 99 000 estimated MDR-TB cases among notified pulmonary TB cases, accounting for approximately 30% of the world's MDR-TB cases in 2014. Six of the 30 high MDR-TB-burden conuntries are in the South-East Asia Region: Bangaledsh, Democratic People's Republic of Korea, India, Indonesia, Myanmar and Thailand. An estimated 210 000 cases (5.2%) of the 4 million TB-incident cases are HIV-positive. This corresponds to 11 per 100 000 and 5% of all estimated TB-incident cases. An estimated 62 000 caes died of HIV-associatied TB in 2014. In alignment with the WHO End-TB Strategy, a new Regional Strategic Plan (2016-2020) has now been developed for TB control in the South-East Asia Region with the vision to have a Region free of TB with zero death, disease and suffering due to TB. All Member States can adopt this vision in their national strategies and plans. The goal for TB control is to End the TB epidemic in the Region by 2035, by adopting and adapting the vision, milestones and targets as outlined in the WHA67.1 resolution. The WHO Regional Office, in coordination with all country offices and international and national partners, continues to support all Member States in their efforts to achieve universal health coverage and to end the TB epidemic.
World Health Organization, Regional Office for South-East Asia. (2016). Tuberculosis control in the South-East Asia Region: Annual Report 2016. World Health Organization. http://www.who.int/iris/handle/10665/205286
MetadataShow full item record
Showing items related by title and MeSH subject.
Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children : expert group meeting report : 2013 World Health Organization (WHO/HTM/TB/2013.14, 2013)
Technique automatisée d’amplification de l’acide nucléique en temps réel pour la détection rapide et simultanée de la tuberculose et de la résistance à la rifampicine : système Xpert MTB/RIF : déclaration de principe Organisation mondiale de la Santé (WHO/HTM/TB/2011.4, 2011)